.
MergerLinks Header Logo

Announced

Permira-backed Neuraxpharm completed the acquisition of Medinutrix.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Pharmaceuticals

Single Bidder

Domestic

Ireland

Friendly

pharmaceutical desctribution

Acquisition

Private

Pending

pharmaceutical distribution

Majority

Private Equity

Synopsis

Edit

Permira-backed Neuraxpharm, an European specialty pharmaceutical company, completed its acquisition of Medinutrix, an Irish pharma company.Financial terms were not disclosed. “When we founded Medinutrix, we dedicated ourselves to be a specialty pharmaceutical company delivering real value to patients and healthcare professionals. We are enthusiastic about our future as Neuraxpharm Ireland and the opportunity to work with such a dynamic and experienced team, to bring further innovative medicines to patients in Ireland,” Dave Shanahan, Medinutrix Founder.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US